Insys Therapeutics Inc (INSYQ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2013 | 12-2012 | 12-2011 | 12-2009 | 12-2008 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 45,782 | 361 | 11 | 5,040 | 7,290 |
| Marketable Securities | N/A | N/A | N/A | 13,950 | 2,370 |
| Receivables | 16,313 | 3,089 | N/A | N/A | N/A |
| Inventories | 14,528 | 7,095 | 6,735 | N/A | N/A |
| Income taxes - deferred | 3,800 | N/A | N/A | N/A | N/A |
| Other current assets | 0 | 0 | 0 | 310 | 0 |
| TOTAL | $82,150 | $11,889 | $7,908 | $19,300 | $9,660 |
| Non-Current Assets | |||||
| PPE Net | 10,127 | 6,791 | 7,479 | N/A | N/A |
| Investments And Advances | 0 | 0 | 0 | 0 | 12,320 |
| Intangibles | 0 | 0 | 5,403 | 0 | 0 |
| Other Non-Current Assets | 8,281 | 61 | 170 | 0 | 0 |
| TOTAL | $18,408 | $6,852 | $13,052 | $N/A | $12,320 |
| Total Assets | $100,558 | $18,741 | $20,960 | $20,200 | $23,350 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 11,858 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 12,173 | 6,479 | 7,902 | 0 | 0 |
| Accrued Expenses | 8,908 | 1,392 | 476 | 60 | N/A |
| Other current liabilities | N/A | N/A | 508 | N/A | N/A |
| TOTAL | $21,081 | $83,419 | $61,701 | $16,070 | $3,540 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | 5,307 | N/A | N/A | N/A |
| Other Non-Current Liabilities | 0 | 0 | 2,472 | 30 | 9,250 |
| TOTAL | $N/A | $N/A | $2,472 | $30 | $9,250 |
| Total Liabilities | $21,081 | $83,419 | $64,173 | $16,110 | $12,800 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 66,820 | N/A | N/A | N/A | N/A |
| Common Shares | 332 | N/A | N/A | N/A | N/A |
| Retained earnings | -89,033 | -129,410 | -105,032 | -287,910 | -280,450 |
| Other shareholders' equity | -21 | 128 | 128 | 291,990 | 291,000 |
| TOTAL | $79,477 | $-64,678 | $-43,213 | $4,080 | $10,550 |
| Total Liabilities And Equity | $100,558 | $18,741 | $20,960 | $20,190 | $23,350 |